Preventing blindness in retinal disease: Ciliary neurotrophic factor intraocular implants

Canadian Journal of Ophthalmology

Volumn 42, Issue 3, 2007, Pages 399-402

  MacDonald, Ian M ^a   Sauvé, Yves ^b   Sieving, Paul A ^a  

^a NATIONAL EYE INSTITUTE   (United States)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Ciliary neurotrophic factor; Encapsulated cell therapy; Macular degeneration; Neuroprotection; Retina; Retinitis pigmentosa

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CILIARY NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR;

AMYOTROPHIC LATERAL SCLEROSIS; BLINDNESS; CATARACT; CELL ENCAPSULATION; CELL THERAPY; CHOROID DETACHMENT; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG DOSE ESCALATION; DRUG MECHANISM; DRUG SAFETY; HUMAN; INTRAOCULAR PRESSURE; LENS IMPLANT; NONHUMAN; PARKINSON DISEASE; PROPHYLAXIS; RETINA DISEASE; RETINITIS PIGMENTOSA; TREATMENT OUTCOME;

EID: 34250615443     PISSN: 00084182     EISSN: 17153360     Source Type: Journal    
DOI: 10.3129/I07-039     Document Type: Conference Paper

References (17)

1. Colangelo AM, Finotti N, Ceriani M, et al. Recombinant human nerve growth factor with a marked activity in vitro and in vivo. Proc Natl Acad Sci U S A 2005;102:18658-63.
2. Gill SS, Patel NK, Hotton GR, et al. Direct brain infusion of glial cell line-derived neurotrophic factor in Parkinson disease. Nature Med 2003;9:588-95.
3. Nutt JG, Burchiel KJ, Comella CL, et al. ICV GDNF Study Group. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 2003;60:69-73.
4. Lang AE, Gill S, Patel NK, et al. Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease. Ann Neurol 2006;59:459-66.
5. Zhang Z, Miyoshi Y, Lapchak PA, et al. Dose response to intraventricular glial cell line-derived neurotrophic factor administration in parkinsonian monkeys. J Pharmacol Exp Ther 1997;282:1396-401.
6. Ochs G, Penn RD, York M, et al. A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:201-6.
7. Bongioanni P, Reali C, Sogos V. Ciliary neurotrophic factor (CNTF) for amyotrophic lateral sclerosis/motor neuron disease (review). Cochrane Database Syst Rev 2004;3: CD004302.
8. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature 1990;347:83-6.
9. Beltran WA, Zhang Q, Kijas JW, et al. Cloning, mapping, and retinal expression of the canine ciliary neurotrophic factor receptor alpha (CNTFRalpha). Invest Ophthalmol Vis Sci 2003;44:3642-9.
10. Liu C, Peng M, Laties AM, Wen R. Preconditioning with bright light evokes a protective response against light damage in the rat retina. J Neurosci 1998;18:1337-44.
11. Valter K, Bisti S, Gargini C, et al. Time course of neurotrophic factor upregulation and retinal protection against light-induced damage after optic nerve section. Invest Ophthalmol Vis Sci 2005;46:1748-54.
12. Tao W, Wen R, Goddard MB, et al. Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa. Invest Ophthalmol Vis Sci 2002;43:3292-8.
13. Lavail MM. Survival factors for treatment of retinal degenerative disorders: preclinical gains and issues for translation into clinical studies. Retina 2005;8:S25-S26.
14. Tao W. Application of encapsulated cell technology for retinal degenerative diseases. Expert Opin Biol Ther 2006;6:717-26.
15. Thanos CG, Bell WJ, O'Rourke P, et al. Sustained secretion of ciliary neurotrophic factor to the vitreous, using the encapsulated cell therapy-based NT-501 intraocular device. Tissue Eng 2004;10:1617-22.
16. Sieving PA, Caruso RC, Tao W, et al. Ciliary neurotrophic factor (CNTF) for human retinal degeneration: Phase I trial of CNTF delivered by encapsulated cell intraocular implants. Proc Natl Acad Sci U S A 2006;103:3896-901.
17. MacDonald IM. Genetic aspects of age-related macular degeneration. Can J Ophthalmol 2005;40:288-92.